Helix BioPharma Corp. and Moffitt Cancer Center to Present at the AACR Annual Meeting 2019 in Atlanta

NEXT STORY
Gritstone Oncology Announces Oral Presentation on MHC Class II Antigen Prediction at the AACR Annual Meeting in April 2019
PREV STORY
PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2018 Results and Provides First Quarter and Full Year 2019 Guidance
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kessler Topaz Meltzer & Check, LLP:  Securities Fraud Class Action Filed Against Chembio Diagnostics, Inc. – CEMI

author_avatar
NASDAQ Market News

Inovio Applies to Cease Reporting to Canadian Securities Regulatory Authorities; NASDAQ Listing and US Reporting Unaffected

PLYMOUTH MEETING, Pa., Nov. 25, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...

author_avatar
NASDAQ Market News

Aladote® is concluded as safe in first clinical study – PledPharma aims to apply for Orphan Drug Status in the US

Today PledPharma (publ) announces that the company has received a positive conclusion of the ...

author_avatar
NASDAQ Market News